Abstract

BackgroundSeveral research applications involving platelets, such as proteomic and transcriptomic analysis, require samples with very low numbers of contaminating leukocytes, which have considerably higher RNA and protein content than platelets. We sought to develop a platelet purification protocol that would minimize contamination, involve minimal centrifugation steps, and yield highly pure platelet samples derived from low volume whole blood samples from healthy dogs.ResultsUsing an optimized OptiPrep density gradient technique, platelet recovery was 51.56% with 99.99% platelet purity and leukocyte contamination of 100 leukocytes per 108 platelets, on average. Platelet samples were subjected to additional purification with CD45-labeled Dynabeads after density barrier centrifugation resulting in a 95-fold depletion of residual leukocytes. Platelets purified using these methods remained inactivated as assessed by Annexin V and P-selectin labeling with flow cytometry.ConclusionsThe use of OptiPrep density gradient is a quick method for obtaining highly purified platelet samples from low volumes of canine whole blood with minimal contamination. Additional depletion of residual leukocytes can be achieved using CD45-labeled beads. These platelet samples can then be used for many downstream applications that require ultra-pure platelet samples such as RNA and protein analysis.

Highlights

  • Several research applications involving platelets, such as proteomic and transcriptomic analysis, require samples with very low numbers of contaminating leukocytes, which have considerably higher RNA and protein content than platelets

  • On average, optimized density barrier centrifugation resulted in a 24,574-fold decrease of the leukocyte to platelet ratio from whole blood

  • Reduction of leukocyte contamination by bead separation Throughout optimization of the OptiPrep density barrier purification technique, CD45-labeled Dynabeads were tested as a method to remove additional residual leukocytes

Read more

Summary

Introduction

Several research applications involving platelets, such as proteomic and transcriptomic analysis, require samples with very low numbers of contaminating leukocytes, which have considerably higher RNA and protein content than platelets. We sought to develop a platelet purification protocol that would minimize contamination, involve minimal centrifugation steps, and yield highly pure platelet samples derived from low volume whole blood samples from healthy dogs. The role of platelets in angiogenesis is being evaluated more closely as a potential modulator of tumor progression and metastasis. The continued exploration of platelets and their roles in hemostasis, healing, or cancer progression and metastasis requires increasingly pure platelet isolates. Newer methods being employed in the study of disease include proteomic, transcriptomic and metabolic studies that require platelet samples with very low levels of leukocyte contamination. Current commonly used methods for producing platelet rich plasma (PRP) can yield up to

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.